Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis

Details for Australian Patent Application No. 2003267283 (hide)

Owner The Regents Of The University Of California

Inventors Hellerstein, Marc K.

Agent Davies Collison Cave

Pub. Number AU-B-2003267283

PCT Number PCT/US03/29361

PCT Pub. Number WO2004/025270

Priority 60/410,352 13.09.02 US

Filing date 15 September 2003

Wipo publication date 30 April 2004

Acceptance publication date 3 September 2009

International Classifications

G01N 27/62 (2006.01) Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means - by investigating the ionisation of gases

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 49/00 (2006.01) Preparations for testing

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/12 (2006.01) Preparations containing radioactive substances for use in therapy or testing - characterised by a special physical form, e.g. emulsion, microcapsules, liposomes

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

G01N 27/64 (2006.01) Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means - using wave or particle radiation to ionise a gas, e.g. in an ionisation chamber

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/60 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving radioactive labelled substances

G01N 33/92 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 60/410,352 13.09.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-B-2003267283

26 May 2005 Amendment Made

  The nature of the amendment is: Amend the invention title from Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis to Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis

3 September 2009 Application Accepted

  Published as AU-B-2003267283

7 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003267284-DISK MIRROR ARCHITECTURE FOR DATABASE APPLIANCE

2003267282-BATTERY WITH INCREASED ELECTRODE INTERFACIAL SURFACE AREA AND INCREASED ACTIVE MATERIALS